Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical features of GCA/PMR.

G G Hunder1

  • 1Department of Internal Medicine/Rheumatology, Mayo Clinic, Rochester, Minnesota 55901, USA.

Clinical and Experimental Rheumatology
|August 19, 2000
PubMed
Summary

Giant cell arteritis (GCA) is a large artery vasculitis affecting older adults, presenting with diverse symptoms beyond cranial issues. Early visual loss and late aortic aneurysm are key concerns, managed with glucocorticoids despite common side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prominent perivascular enhancement in primary central nervous system vasculitis.

Clinical and experimental rheumatology·2008
Same author

Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy.

Rheumatology (Oxford, England)·2008
Same author

Primary CNS vasculitis with spinal cord involvement.

Neurology·2008
Same author

Cervical interspinous bursitis in active polymyalgia rheumatica.

Annals of the rheumatic diseases·2008
Same author

Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis.

Clinical and experimental rheumatology·2004
Same author

Vasculitis. A collection of pearls and myths.

Rheumatic diseases clinics of North America·2001

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Vascular Biology

Background:

  • Giant cell arteritis (GCA) is a prevalent inflammatory condition affecting large arteries, primarily in individuals over 50.
  • The exact etiology of GCA remains unknown, but it is characterized by inflammation of the aorta and its branches.
  • Incidence increases with age, posing a significant health concern for the aging population.

Purpose of the Study:

  • To provide a comprehensive overview of Giant Cell Arteritis.
  • To highlight the diverse clinical presentations and potential complications of GCA.
  • To discuss current management strategies and their associated challenges.

Main Methods:

  • Review of existing literature on Giant Cell Arteritis.
  • Analysis of epidemiological data regarding GCA incidence and risk factors.
  • Synthesis of information on clinical manifestations, diagnostic criteria, and treatment outcomes.

Main Results:

  • GCA commonly affects individuals in middle age and older, with incidence rising with age.
  • Inflammatory lesions target large arteries rich in elastic tissue, leading to varied symptoms.
  • Cranial symptoms (headache, jaw claudication, visual disturbances) are frequent, but non-specific symptoms (fever, malaise, anemia) are also common.
  • GCA can have a relapsing-remitting course, with visual loss and aortic aneurysm as significant complications.
  • Patients typically respond to glucocorticoids, though side effects are a frequent concern.

Conclusions:

  • Giant cell arteritis is a complex vasculitis with a broad clinical spectrum and potential for severe complications.
  • Prompt diagnosis and management, primarily with glucocorticoids, are crucial to prevent irreversible damage, particularly visual loss.
  • Ongoing research is needed to understand GCA's pathogenesis and develop safer, more effective long-term therapies.

Related Experiment Videos